Edgewise Therapeutics, Inc.
EWTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001710072
In the last 90 days, Edgewise Therapeutics, Inc. insiders filed 0 open-market purchases and 6 sales; 226 institutions reported holding it in 13F filings for Q2 2026, worth $4.82B in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Edgewise Therapeutics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 46
- +15 vs. Q1 2021
- Shares held
- 47.9M
- +2.20M (+4.8%) vs. Q1 2021
- Total value
- $1.03B
- −$449.0M (−30.4%) vs. Q1 2021
- New holders
- 23
- 9 more added
- Sold out
- 8
- 6 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EWTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 226 | $4.82B |
| Q1 2026 | 214 | $3.72B |
| Q4 2025 | 199 | $3.02B |
| Q3 2025 | 173 | $1.82B |
| Q2 2025 | 179 | $1.56B |
| Q1 2025 | 193 | $2.32B |
| Q4 2024 | 201 | $2.64B |
| Q3 2024 | 177 | $2.71B |
| Q2 2024 | 140 | $1.83B |
| Q1 2024 | 129 | $1.67B |
| Q4 2023 | 116 | $871.4M |
| Q3 2023 | 85 | $392.2M |
| Q2 2023 | 95 | $538.8M |
| Q1 2023 | 85 | $443.1M |
| Q4 2022 | 90 | $594.1M |
| Q3 2022 | 94 | $633.5M |
| Q2 2022 | 78 | $405.7M |
| Q1 2022 | 72 | $523.5M |
| Q4 2021 | 58 | $769.4M |
| Q3 2021 | 48 | $795.8M |
| Q2 2021 | 46 | $1.03B |
| Q1 2021 | 31 | $1.48B |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Edgewise Therapeutics, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| State of Wyoming | 42 | $1.00K | 0.00% | +42 | New |
| Tower Research Capital LLC (TRC) | 294 | $6.00K | 0.00% | +294 | New |
| Morgan Stanley | 462 | $10.0K | 0.00% | +462 | New |
| Citigroup Inc | 587 | $13.0K | 0.00% | +587 | New |
| Royal Bank of Canada | 844 | $18.0K | 0.00% | +844 | New |
| UBS Group AG | 868 | $19.0K | 0.00% | +868 | New |
| Ameritas Investment Partners, Inc. | 967 | $21.0K | 0.00% | +967 | New |
| Legal & General Group Plc | 1,865 | $40.0K | 0.00% | +1,865 | New |
| STRS Ohio | 2,900 | $61.0K | 0.00% | +2,900 | New |
| American International Group, Inc. | 6,914 | $147.0K | 0.00% | +6,914 | New |
| Deutsche Bank AG | 7,345 | $156.0K | 0.00% | +7,345 | New |
| Pinz Capital Management, LP | 8,705 | $186.0K | 0.06% | +8,705 | New |
| JPMorgan Chase & Co | 10,123 | $216.0K | 0.00% | +10,123 | New |
| New York State Common Retirement Fund | 10,600 | $226.0K | 0.00% | +10,600 | New |
| California State Teachers Retirement System | 17,031 | $363.0K | 0.00% | +17,031 | New |
| HighVista Strategies LLC | 27,467 | $586.0K | 0.42% | +27,467 | New |
| Bank of New York Mellon Corp | 28,473 | $607.0K | 0.00% | +28,473 | New |
| Soleus Capital Management, L.P. | 31,300 | $668.0K | 0.10% | −68,700−68.7% | Reduced |
| D. E. Shaw & Co., Inc. | 46,167 | $985.0K | 0.00% | +46,167 | New |
| Nuveen Asset Management, LLC | 46,840 | $999.0K | 0.00% | +46,840 | New |
| Charles Schwab Investment Management Inc | 81,074 | $1.73M | 0.00% | +81,074 | New |
| Octagon Capital Advisors LP | 125,000 | $2.67M | 0.55% | 00.0% | Unchanged |
| Northern Trust Corp | 126,729 | $2.70M | 0.00% | +126,729 | New |
| State Street Corp | 177,502 | $3.79M | 0.00% | +177,502 | New |
| Credit Suisse AG | 211,168 | $4.50M | 0.00% | +127,116+151.2% | Added |
| Geode Capital Management, LLC | 242,422 | $5.17M | 0.00% | +242,422 | New |
| American Century Companies Inc | 294,310 | $6.28M | 0.00% | +15,733+5.6% | Added |
| Norges Bank | 301,691 | $6.43M | 0.00% | −147,309−32.8% | Reduced |
| Woodline Partners LP | 354,489 | $7.56M | 0.14% | −2,940−0.8% | Reduced |
| Baker Bros. Advisors LP | 500,000 | $10.7M | 0.05% | 00.0% | Unchanged |
| BlackRock Inc. | 567,458 | $12.1M | 0.00% | +511,973+922.7% | Added |
| Vanguard Group Inc | 582,863 | $12.4M | 0.00% | +462,863+385.7% | Added |
| Federated Hermes, Inc. | 700,000 | $14.9M | 0.03% | +83,276+13.5% | Added |
| Wellington Management Group LLP | 741,588 | $15.5M | 0.00% | −824−0.1% | Reduced |
| EcoR1 Capital, LLC | 1,224,175 | $26.1M | 0.98% | 00.0% | Unchanged |
| Logos Global Management LP | 1,231,812 | $26.3M | 2.25% | +175,000+16.6% | Added |
| Janus Henderson Group PLC | 1,789,280 | $36.7M | 0.02% | −351,628−16.4% | Reduced |
| New Leaf Venture Partners, L.L.C. | 1,553,661 | $43.8M | 14.39% | 00.0% | Unchanged |
| Citadel Advisors LLC | 2,460,151 | $51.2M | 0.05% | +78,003+3.3% | Added |
| FMR LLC | 2,415,218 | $51.5M | 0.00% | +884,800+57.8% | Added |
| Ra Capital Management, L.P. | 2,613,623 | $55.7M | 0.89% | 00.0% | Unchanged |
| Viking Global Investors LPSuperinvestorViking Global Investors | 2,727,249 | $58.2M | 0.18% | −625,000−18.6% | Reduced |
| Cormorant Asset Management, LP | 3,140,914 | $66.5M | 2.59% | +800,000+34.2% | Added |
| Deerfield Management Company, L.P. (Series C) | 3,933,137 | $83.9M | 1.49% | 00.0% | Unchanged |
| Novo Holdings A/S | 5,587,207 | $119.2M | 5.29% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 13,944,680 | $297.4M | 3.04% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −300,000−100.0% | Sold out |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −65,263−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −60,077−100.0% | Sold out |
| Caas Capital Management LP | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −20,185−100.0% | Sold out |
| Landscape Capital Management, L.L.C. | 0 | $0 | 0.00% | −8,923−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −8,300−100.0% | Sold out |